zofenopril has been researched along with hydrogen sulfide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brancaleone, V; Bucci, M; Calderone, V; Cantalupo, A; Cirino, G; Evangelista, S; Papapetropoulos, A; Vellecco, V; Zhou, Z | 1 |
Ali, MJ; Bradley, JM; Cirino, G; Donnarumma, E; Evangelista, S; Goodchild, TT; Islam, KN; Jenkins, JS; Lefer, DJ; Organ, CL; Patel, RA; Polhemus, DJ; Rushing, AM; Scarborough, AL | 1 |
de Nucci, G; Dicay, M; MacNaughton, WK; Vaughan, D; Wallace, JL | 1 |
Allagnat, F; Corpataux, JM; Déglise, S; Deslarzes-Dubuis, C; Lambelet, M; Longchamp, A; Macabrey, D; Ozaki, CK | 1 |
1 review(s) available for zofenopril and hydrogen sulfide
Article | Year |
---|---|
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Naproxen | 2018 |
3 other study(ies) available for zofenopril and hydrogen sulfide
Article | Year |
---|---|
Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cystathionine gamma-Lyase; Hydrogen Sulfide; Male; Rats, Inbred SHR; Rats, Inbred WKY | 2014 |
Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Topics: Animals; Antihypertensive Agents; Biological Availability; Blotting, Western; Captopril; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Heart; Hydrogen Sulfide; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Ramipril; Random Allocation; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Sulfurtransferases; Swine; Swine, Miniature; Troponin I | 2016 |
Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Carotid Stenosis; Cells, Cultured; Disease Models, Animal; Humans; Hydrogen Sulfide; Hyperplasia; Hypertension; Male; Mice; Myocytes, Smooth Muscle; Organ Culture Techniques; Primary Cell Culture; Tunica Intima; Veins | 2022 |